NDC 73377-325 - Ondansetron HCl Dihydrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-325
- Package NDCs from labels
- 73377-325-01, 73377-325-02
- Manufacturer
- AX Pharmaceutical Corp | NATCO PHARMA LIMITED
- Effective date
- 2025-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron HCl Dihydrate - AX Pharmaceutical Corp | NATCO PHARMA LIMITED | AX Pharmaceutical Corp | NATCO PHARMA LIMITED | 2025-09-17 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-325-01 | Ondansetron HCl Dihydrate | 100 g in 1 JAR | POWDER | 100 | 2 | |
| 73377-325-02 | Ondansetron HCl Dihydrate | 500 g in 1 JAR | POWDER | 500 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | 3aeb533a-e72c-4af8-9867-b71d2eba9a49 | 2024-08-20 | Warnings, Adverse reactions | NMH84OZK2B |
| ondansetron | ONDANSETRON HYDROCHLORIDE | Sagent Pharmaceuticals | ba0f8f13-1f7d-44e0-9c0f-0b43a9e8e3a7 | 2024-08-15 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | 115e8fb5-61f5-4719-8eb3-063b7ca194ae | 2024-08-08 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | d6694136-7591-4f23-8415-f2aa3c8bab40 | 2024-07-16 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 8cea2f3a-cfa5-4a68-9ff4-b5a5a2085d08 | 2024-06-25 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 1b406d22-f1bf-460d-e063-6294a90a6b6f | 2024-06-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 91bfbc0e-86a3-8ac6-e053-2a95a90af432 | 2024-06-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NUCARE PHARMACEUTICALS INC | 8d696b8c-eba6-505e-e053-2995a90acb5d | 2024-06-18 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 7f315229-7e8f-67fd-e053-2a91aa0a8cb6 | 2024-06-12 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NuCare Pharmceuticals,Inc. | 67395789-0ac7-2244-e053-2a91aa0a652a | 2024-06-07 | Warnings, Adverse reactions | NMH84OZK2B |
| ondansetron hydrochloride | ONDANSETRON HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 00327696-c496-4c83-a63e-9e29fd6246d4 | 2024-04-24 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | a62e2a6a-6235-7580-e053-2a95a90aa2b0 | 2024-02-26 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 768aa02b-8231-5799-e053-2a91aa0a618d | 2024-02-22 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | cdb2c4b4-a20a-3f8f-e053-2a95a90aaf72 | 2024-01-30 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Eugia US LLC | 1cc94c7a-617c-4238-8248-e3fabc9612c7 | 2024-01-02 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Fresenius Kabi USA, LLC | 6a231919-6837-4b09-b66d-3706432b9702 | 2023-11-20 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Fresenius Kabi USA, LLC | e0050959-c14c-41b6-9a92-fadc5f6feff3 | 2023-11-02 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | A-S Medication Solutions | 674ea285-8f84-4603-9655-82200c523fe5 | 2023-10-25 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | Chartwell RX, LLC | 88b7432b-f5a7-40f3-9b0c-e7b125f5103c | 2023-10-05 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON HYDROCHLORIDE | Fresenius Kabi USA, LLC | d89017aa-b8c3-4fd2-8e68-44e2cfd6f290 | 2023-08-16 | Warnings, Adverse reactions | NMH84OZK2B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.